Crossmark

Combination of disease burden before allogeneic transplantation and early post-transplant minimal residual disease predicts survival in patients with acute myeloid leukemia

Crossref DOI link: https://doi.org/10.1007/s00277-025-06325-x

Published Online: 2025-04-25

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stock, Claudia Núñez-Torrón https://orcid.org/0000-0002-2881-161X
Chillón, Carlos Jiménez

Hernández, Clara López

Moro, Fernando Martín

Palomanes, Juan Marquet

Villaespesa, Miguel Piris

de Abia, Alejandro Luna

Santiago, Ernesto Roldán

Martín, Eulalia Rodríguez

Rodríguez, Anabelle Chinea

Gutiérrez, Valentín García

Jiménez, Gemma Moreno

Jiménez, Javier López

Puente, Pilar Herrera
Funding

Funding for this research was provided by:

Universidad de Alcalá
License Information

Text and Data Mining valid from 2025-04-01

Version of Record valid from 2025-04-25
More Information

Article History

Received: 15 January 2025

Accepted: 16 March 2025

First Online: 25 April 2025

Declarations

:

: The authors declare no competing interests.

: The authors have nothing to disclose.

Document is current

Any future updates will be listed below